Shanghai Haohai Biological Technology Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shanghai haohai biological technology ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shanghai Haohai Biological Technology Ltd Today - Breaking & Trending Today

ArcScan, Inc. unterzeichnet endgültiges Abkommen mit Shanghai Haohai Biological Technology Ltd. über Preferred Series B-Investition in Höhe von 11,15 Mio. USD.


(1)
Golden, Colorado (ots/PRNewswire) - ArcScan, Inc., der Entwickler des hochmodernen ophthalmologischen Ultraschallbildgebungsgeräts ArcScan Insight® 100 mit Hauptsitz in Golden, Colorado, gibt die Ausführung einer Aktienkaufvereinbarung mit Shanghai Haohai Biological Technology Ltd. ( Haohai ) über eine Preferred Series B -Investition in ArcScan in Höhe von 11,15 Millionen USD bekannt. Inc. Haohai ist ein führendes chinesisches Unternehmen für Augenheilkunde und medizinische Ästhetik mit Sitz in Shanghai, das an den Börsen in Hongkong (6826.HK) und Shanghai (688366.SH) gehandelt wird.
YAFO Capital aus Shanghai und Auctus Capital Partners aus Chicago fungierten bei dieser Transaktion als Finanzberater für ArcScan, Inc. ....

United States , Hong Kong , City Of , United Kingdom , Andrew Levien , Yulia Mobley , Olivia Chen , Chinese Company , Weill University , Haohai Biological Technology , Information On The Company Is Available , Shanghai Haohai Biological Technology Ltd , Preferred Series Produced Byb Investition , Implementation Of An Aktienkaufvereinbarung , Preferred Series Produced , Yafo Capital , Auctus Capital Partner , Medical Needs , Haohai Biological , Arcscan Technologie The , Beam Swept Highly Liquid Interface Technologie , Patient Is Sitting , Eyeseal Disposables , Cross Contamination , Tendency And , London Vision Clinic ,

Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.


Share this article
Share this article
WOBURN, Mass., March 9, 2021 /PRNewswire/  Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with Shanghai Haohai Biological Technology Ltd. ( Haohai ) that will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eirion s products for the territory of China in exchange for an upfront payment in the amount of $8 million. The deal is structured in segments over the next approximately 18 months. Haohai is a leading Chinese aesthetic medicine company headquartered in Shanghai and is publicly traded on the Hong Kong (6826.HK) and Shanghai (688366.SS) stock exchanges.  ....

United States , Hong Kong , Yongtai Hou , Megan Driscoll , Jon Edelson , Haohai Biological Technology , Skin Health Innovation Competition , Eirion Technology , Inquiries Contact , Eirion Therapeutics Inc , Shanghai Haohai Biological Technology Ltd , Eirion Therapeutics , Shanghai Haohai Biological Technology , Preferred Stock , Kenneth Beer , Clinical Dermatology , Skin Health Innovation , Biological Technology , Press Inquiries Contact , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , மேகன் ட்ரிஸ்கல் , ஜான் எடெல்சன் , தோல் ஆரோக்கியம் கண்டுபிடிப்பு போட்டி , விசாரணைகள் தொடர்பு , ப்ரிஃபர்ட் ஸ்டாக் ,